je.st
news
UPDATE 1-Europe pushes back verdict on Bristol immune system cancer drug
2015-03-27 17:39:02| Biotech - Topix.net
European regulators have postponed a decision on whether to recommend approval of a closely watched Bristol-Myers Squibb drug that helps the immune system fight cancer, officials said on Friday. Nivolumab, which is already approved in the United States under the brand name Opdivo for melanoma and lung cancer, was on the agenda at a monthly meeting of European Medicines Agency experts, but no verdict was reached.
Tags: back
system
update
drug
Category:Biotechnology and Pharmaceuticals